Skip to main content
Top
Published in: Journal of Translational Medicine 1/2024

Open Access 01-12-2024 | Polycystic Ovary Syndrome | Research

High-fat and high-sucrose diet impairs female reproduction by altering ovarian transcriptomic and metabolic signatures

Authors: Congcong Liu, Yunde Dou, Mengge Zhang, Shan Han, Shourui Hu, Yuxuan Li, Zhiheng Yu, Yue Liu, Xiaofan Liang, Zi-Jiang Chen, Han Zhao, Yuqing Zhang

Published in: Journal of Translational Medicine | Issue 1/2024

Login to get access

Abstract

Background

Excessive energy intake in modern society has led to an epidemic surge in metabolic diseases, such as obesity and type 2 diabetes, posing profound threats to women’s reproductive health. However, the precise impact and underlying pathogenesis of energy excess on female reproduction remain unclear.

Methods

We established an obese and hyperglycemic female mouse model induced by a high-fat and high-sucrose (HFHS) diet, then reproductive phenotypes of these mice were evaluated by examing sexual hormones, estrous cycles, and ovarian morphologies. Transcriptomic and precise metabolomic analyses of the ovaries were performed to compare the molecular and metabolic changes in HFHS mice. Finally, orthogonal partial least squares discriminant analysis was performed to compare the similarities of traits between HFHS mice and women with polycystic ovary syndrome (PCOS).

Results

The HFHS mice displayed marked reproductive dysfunctions, including elevated serum testosterone and luteinizing hormone levels, irregular estrous cycles, and impaired folliculogenesis, mimicking the clinical manifestations of women with PCOS. Precise metabolomic overview suggested that HFHS diet disrupted amino acid metabolism in the ovaries of female mice. Additionally, transcriptional profiling revealed pronounced disturbances in ovarian steroid hormone biosynthesis and glucolipid metabolism in HFHS mice. Further multi-omics analyses unveiled prominent aberration in ovarian arginine biosynthesis pathway. Notably, comparisons between HFHS mice and a cohort of PCOS patients identified analogous reproductive and metabolic signatures.

Conclusions

Our results provide direct in vivo evidence for the detrimental effects of overnutrition on female reproduction and offer insights into the metabolic underpinnings of PCOS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Qiu HL, Fan SJ, Zhou KX, He ZN, Browning MHEM, Knibbs LD, et al. Global burden and drivers of hyperglycemia estimates and predictions from 1990 to 2050. Innovation. 2023;4(4):100450.PubMedPubMedCentral Qiu HL, Fan SJ, Zhou KX, He ZN, Browning MHEM, Knibbs LD, et al. Global burden and drivers of hyperglycemia estimates and predictions from 1990 to 2050. Innovation. 2023;4(4):100450.PubMedPubMedCentral
2.
go back to reference Peng JY, Lü MH, Wang P, Peng Y, Tang XW. The global burden of metabolic disease in children and adolescents: data from the Global Burden of Disease 2000–2019. Metab Clin Exp. 2023;148:155691.PubMedCrossRef Peng JY, Lü MH, Wang P, Peng Y, Tang XW. The global burden of metabolic disease in children and adolescents: data from the Global Burden of Disease 2000–2019. Metab Clin Exp. 2023;148:155691.PubMedCrossRef
3.
go back to reference Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. Jama-J Am Med Assoc. 2016;315(21):2284–91.CrossRef Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. Jama-J Am Med Assoc. 2016;315(21):2284–91.CrossRef
4.
go back to reference Koning AMH, Kuchenbecker WKH, Groen H, Hoek A, Land JA, Khan KS, et al. Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update. 2010;16(3):246–54.PubMedCrossRef Koning AMH, Kuchenbecker WKH, Groen H, Hoek A, Land JA, Khan KS, et al. Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update. 2010;16(3):246–54.PubMedCrossRef
5.
go back to reference Penzias A. Obesity and reproduction: a committee opinion. Fertil Steril. 2021;116(5):1266–85.CrossRef Penzias A. Obesity and reproduction: a committee opinion. Fertil Steril. 2021;116(5):1266–85.CrossRef
6.
go back to reference Kim J, Patounakis G, Juneau C, Morin S, Neal S, Bergh P, et al. The appraisal of body content (ABC) trial: increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes. Fertil Steril. 2021;116(2):444–52.PubMedCrossRef Kim J, Patounakis G, Juneau C, Morin S, Neal S, Bergh P, et al. The appraisal of body content (ABC) trial: increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes. Fertil Steril. 2021;116(2):444–52.PubMedCrossRef
7.
go back to reference Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction (Cambridge, England). 2010;140(3):347–64.PubMedCrossRef Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction (Cambridge, England). 2010;140(3):347–64.PubMedCrossRef
8.
go back to reference Barber TM, Hanson P. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.PubMedPubMedCentralCrossRef Barber TM, Hanson P. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.PubMedPubMedCentralCrossRef
9.
go back to reference Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metab Clin Exp. 2019;92:108–20.PubMedCrossRef Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metab Clin Exp. 2019;92:108–20.PubMedCrossRef
10.
go back to reference Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update. 2017;23(6):681–705.PubMedCrossRef Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update. 2017;23(6):681–705.PubMedCrossRef
11.
go back to reference Xu HY, Li JY, Jin LY, Zhang D, Chen B, Liu XM, et al. Intrauterine hyperglycemia impairs endometrial receptivity via up-regulating SGK1 in diabetes. Sci China Life Sci. 2022;65(8):1578–89.ADSPubMedCrossRef Xu HY, Li JY, Jin LY, Zhang D, Chen B, Liu XM, et al. Intrauterine hyperglycemia impairs endometrial receptivity via up-regulating SGK1 in diabetes. Sci China Life Sci. 2022;65(8):1578–89.ADSPubMedCrossRef
12.
go back to reference Frank LA, Sutton-McDowall ML, Brown HM, Russell DL, Gilchrist RB, Thompson JG. Hyperglycaemic conditions perturb mouse oocyte in vitro developmental competence via beta-O-linked glycosylation of Heat shock protein 90. Hum Reprod. 2014;29(6):1292–303.PubMedCrossRef Frank LA, Sutton-McDowall ML, Brown HM, Russell DL, Gilchrist RB, Thompson JG. Hyperglycaemic conditions perturb mouse oocyte in vitro developmental competence via beta-O-linked glycosylation of Heat shock protein 90. Hum Reprod. 2014;29(6):1292–303.PubMedCrossRef
13.
go back to reference Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod (Oxford, England). 2004;19(1):41–7. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod (Oxford, England). 2004;19(1):41–7.
14.
go back to reference Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction (Cambridge, England). 2004;127(5):569–80.PubMedCrossRef Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction (Cambridge, England). 2004;127(5):569–80.PubMedCrossRef
15.
go back to reference Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146–59.PubMedCrossRef Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146–59.PubMedCrossRef
16.
go back to reference Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007;80(2):84–97.PubMedCrossRef Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007;80(2):84–97.PubMedCrossRef
17.
go back to reference Zhang Y, Han S, Liu C, Zheng Y, Li H, Gao F, et al. THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic beta-cell function and preserving beta-cell mass. Nat Commun. 2023;14(1):1020.ADSPubMedPubMedCentralCrossRef Zhang Y, Han S, Liu C, Zheng Y, Li H, Gao F, et al. THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic beta-cell function and preserving beta-cell mass. Nat Commun. 2023;14(1):1020.ADSPubMedPubMedCentralCrossRef
18.
go back to reference Tian H, Ni Z, Lam SM, Jiang WX, Li FJ, Du J, et al. Precise metabolomics reveals a diversity of aging-associated metabolic features. Small Methods. 2022;6(7). Tian H, Ni Z, Lam SM, Jiang WX, Li FJ, Du J, et al. Precise metabolomics reveals a diversity of aging-associated metabolic features. Small Methods. 2022;6(7).
19.
go back to reference Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32(2):188.PubMedPubMedCentralCrossRef Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32(2):188.PubMedPubMedCentralCrossRef
20.
go back to reference de Zegher F, Lopez-Bermejo A, Ibáñez L. Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab. 2009;20(9):418–23.PubMedCrossRef de Zegher F, Lopez-Bermejo A, Ibáñez L. Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab. 2009;20(9):418–23.PubMedCrossRef
21.
go back to reference Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment. Nat Rev Endocrinol. 2021;17(9):521–33.PubMedCrossRef Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment. Nat Rev Endocrinol. 2021;17(9):521–33.PubMedCrossRef
22.
go back to reference Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–5.PubMed Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–5.PubMed
23.
go back to reference Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1997;47(1):93–9.PubMedCrossRef Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1997;47(1):93–9.PubMedCrossRef
24.
go back to reference Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.PubMedCrossRef Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.PubMedCrossRef
25.
go back to reference Visser JA. The importance of metabolic dysfunction in polycystic ovary syndrome. Nat Rev Endocrinol. 2021;17(2):77–8.PubMedCrossRef Visser JA. The importance of metabolic dysfunction in polycystic ovary syndrome. Nat Rev Endocrinol. 2021;17(2):77–8.PubMedCrossRef
26.
go back to reference Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab. 2019;14(2):131–43.PubMedPubMedCentralCrossRef Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab. 2019;14(2):131–43.PubMedPubMedCentralCrossRef
27.
go back to reference Moore AM, Prescott M, Campbell RE. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology. 2013;154(2):796–806.PubMedCrossRef Moore AM, Prescott M, Campbell RE. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology. 2013;154(2):796–806.PubMedCrossRef
28.
go back to reference Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4). Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4).
29.
go back to reference Caldwell ASL, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146–59.PubMedCrossRef Caldwell ASL, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146–59.PubMedCrossRef
30.
go back to reference Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109.PubMedCrossRef Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109.PubMedCrossRef
31.
go back to reference Chen X, Merovci A, DeFronzo RA, Tripathy D. Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans. Metab Clin Exp. 2023;142:155512.PubMedCrossRef Chen X, Merovci A, DeFronzo RA, Tripathy D. Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans. Metab Clin Exp. 2023;142:155512.PubMedCrossRef
32.
go back to reference Chen XJ, Liu DF, He WT, Hu HF, Wang WJ. Predictive performance of triglyceride glucose index (TyG index) to identify glucose status conversion: a 5-year longitudinal cohort study in Chinese pre-diabetes people. J Transl Med. 2023;21(1). Chen XJ, Liu DF, He WT, Hu HF, Wang WJ. Predictive performance of triglyceride glucose index (TyG index) to identify glucose status conversion: a 5-year longitudinal cohort study in Chinese pre-diabetes people. J Transl Med. 2023;21(1).
33.
go back to reference Gonzalez F, Sia CL, Shepard MK, Rote NS, Minium J. The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99(11):E2244–51.PubMedPubMedCentralCrossRef Gonzalez F, Sia CL, Shepard MK, Rote NS, Minium J. The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99(11):E2244–51.PubMedPubMedCentralCrossRef
34.
go back to reference Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62(5):904–10.PubMedCrossRef Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62(5):904–10.PubMedCrossRef
35.
go back to reference Shabbir S, Khurram E, Moorthi VS, Eissa YTH, Kamal MA, Butler AE. The interplay between androgens and the immune response in polycystic ovary syndrome. J Transl Med. 2023;21(1). Shabbir S, Khurram E, Moorthi VS, Eissa YTH, Kamal MA, Butler AE. The interplay between androgens and the immune response in polycystic ovary syndrome. J Transl Med. 2023;21(1).
36.
go back to reference Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.PubMedPubMedCentralCrossRef Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.PubMedPubMedCentralCrossRef
37.
go back to reference Luo Z, Zhang T, Chen S. Exercise prescription: pioneering the “third pole” for clinical health management. Research (Wash D C). 2023;28(6):0284.ADS Luo Z, Zhang T, Chen S. Exercise prescription: pioneering the “third pole” for clinical health management. Research (Wash D C). 2023;28(6):0284.ADS
38.
go back to reference Yang H, Pawitan Y, Fang F, Czene K, Ye W. Biomarkers and disease trajectories influencing women’s health: results from the UK biobank cohort. Phenomics. 2022;2(3):184–93.PubMedPubMedCentralCrossRef Yang H, Pawitan Y, Fang F, Czene K, Ye W. Biomarkers and disease trajectories influencing women’s health: results from the UK biobank cohort. Phenomics. 2022;2(3):184–93.PubMedPubMedCentralCrossRef
39.
go back to reference Hou E, Zhao Y, Hang J, Qiao J. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome. Biomed Chromatogr. 2021;35(3): e4993.PubMedCrossRef Hou E, Zhao Y, Hang J, Qiao J. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome. Biomed Chromatogr. 2021;35(3): e4993.PubMedCrossRef
40.
go back to reference Yang Z, Cai X, Xu X, Xu Z, Ye S, Wang Y, et al. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome. Anal Biochem. 2022;647: 114665.PubMedCrossRef Yang Z, Cai X, Xu X, Xu Z, Ye S, Wang Y, et al. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome. Anal Biochem. 2022;647: 114665.PubMedCrossRef
41.
go back to reference Wang S, Mu L, Zhang C, Long X, Zhang Y, Li R, et al. Abnormal activation of tryptophan-kynurenine pathway in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13: 877807.PubMedCrossRef Wang S, Mu L, Zhang C, Long X, Zhang Y, Li R, et al. Abnormal activation of tryptophan-kynurenine pathway in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13: 877807.PubMedCrossRef
42.
go back to reference Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.PubMedPubMedCentralCrossRef Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.PubMedPubMedCentralCrossRef
43.
go back to reference Ye Z, Zhang C, Wang S, Zhang Y, Li R, Zhao Y, et al. Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances. Reprod Biomed Online. 2022;44(4):737–46.PubMedCrossRef Ye Z, Zhang C, Wang S, Zhang Y, Li R, Zhao Y, et al. Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances. Reprod Biomed Online. 2022;44(4):737–46.PubMedCrossRef
44.
go back to reference Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod. 2012;18(11):546–53.PubMedCrossRef Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod. 2012;18(11):546–53.PubMedCrossRef
45.
go back to reference Han Q, Wang J, Li W, Chen ZJ, Du Y. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome. Microbiome. 2021;9(1):101.PubMedPubMedCentralCrossRef Han Q, Wang J, Li W, Chen ZJ, Du Y. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome. Microbiome. 2021;9(1):101.PubMedPubMedCentralCrossRef
46.
go back to reference Krishna MB, Joseph A, Thomas PL, Dsilva B, Pillai SM, Laloraya M. Impaired arginine metabolism coupled to a defective redox conduit contributes to low plasma nitric oxide in polycystic ovary syndrome. Cell Physiol Biochem. 2017;43(5):1880–92.PubMedCrossRef Krishna MB, Joseph A, Thomas PL, Dsilva B, Pillai SM, Laloraya M. Impaired arginine metabolism coupled to a defective redox conduit contributes to low plasma nitric oxide in polycystic ovary syndrome. Cell Physiol Biochem. 2017;43(5):1880–92.PubMedCrossRef
47.
go back to reference Ragy MM, Abdel-Hamid HA, Toni NDM. Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: using either hemin or l-arginine. J Cell Physiol. 2019;234(6):8426–35.PubMedCrossRef Ragy MM, Abdel-Hamid HA, Toni NDM. Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: using either hemin or l-arginine. J Cell Physiol. 2019;234(6):8426–35.PubMedCrossRef
Metadata
Title
High-fat and high-sucrose diet impairs female reproduction by altering ovarian transcriptomic and metabolic signatures
Authors
Congcong Liu
Yunde Dou
Mengge Zhang
Shan Han
Shourui Hu
Yuxuan Li
Zhiheng Yu
Yue Liu
Xiaofan Liang
Zi-Jiang Chen
Han Zhao
Yuqing Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2024
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-024-04952-y

Other articles of this Issue 1/2024

Journal of Translational Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.